(Q53056378)

English

Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

1 reference

based on heuristic

inferred from title

hemodialysis patient

1 reference

based on heuristic

inferred from title

9

object named as

Friedrich K Port

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

5

object named as

Takashi Akiba

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

author name string

Antonio Alberto Lopes

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Jennifer L Bragg-Gresham

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Sylvia P B Ramirez

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Vittorio E Andreucci

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Akira Saito

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Stefan H Jacobson

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Bruce M Robinson

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Nancy A Mason

10

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Eric W Young

11

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

language of work or name

0 references

publication date

14 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

24

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

9

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

2809-2816

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Associations of kidney function with cardiovascular medication use after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Econometrics in outcomes research: the use of instrumental variables

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Losartan and end-organ protection--lessons from the RENAAL study.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Interdialytic weight gain: implications in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP212

21 January 2018

Identifiers

10.1093/NDT/GFP212

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/19443648

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53056378&oldid=2165222332"